Latest News about BMY
Recent news which mentions BMY
22 Top Dividend Stocks to Buy and Hold in 2022
January 02, 2022
From Motley Fool
Best Stocks for 2022: Bristol-Myers Squibb Will Offer Huge Returns
December 30, 2021
Tickers
BMY
From InvestorPlace
Peering Into Bristol-myers Squibb Company's Recent Short Interest
December 29, 2021
Tickers
BMY
From Benzinga
3 Best Buffett Stocks to Buy for the Long Haul
December 24, 2021
From Motley Fool
Bristol Myers Squibb Stock: Bull vs. Bear
December 21, 2021
From Motley Fool
3 Healthcare Stocks That Could Help Make You a Fortune
December 20, 2021
From Motley Fool
The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week
December 19, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021
December 17, 2021
From Benzinga
Here's Why Shares of Bristol Myers Squibb, Eli Lilly, and Pfizer Rocketed Higher This Week
December 17, 2021
From Motley Fool
4 of the Best Stocks to Buy With $100 in 2022
December 16, 2021
From Motley Fool
FDA Approves Bristol Myers' Orencia As First Drug To Prevent Graft-Versus-Host Disease
December 16, 2021
Tickers
BMY
From Benzinga
CNBC's Final Trades: Darden Restaurants, Bristol-Myers Squibb, AIG, And This Stock Which Is The Biggest Breakout
December 15, 2021
From Benzinga
Is It Time to Buy the 8 Worst-Performing Dividend Stocks of 2021?
December 15, 2021
From Motley Fool
3 Stocks That Can Make You Rich in Just a Few Years
December 14, 2021
From InvestorPlace
From Motley Fool
Here's Why Bristol Myers Squibb Stock Is Heating Up Today
December 13, 2021
Tickers
BMY
From Motley Fool
Comparing Data: Sanofi Vs. Johnson & Johnson Multiple Myeloma Therapies In Newly Diagnosed Patients
December 13, 2021
From Benzinga
2 Top Biotech Stocks To Buy Right Now
December 13, 2021
From Motley Fool
The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More
December 12, 2021
From Benzinga
From Benzinga
Here’s a list of favored dividend stocks with room to pay more for investors worried about 2022
December 10, 2021
From MarketWatch
Why You Should Buy Moderna Stock at Every Dip
December 10, 2021
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
From Benzinga
3 Must-Own Dividend Stocks in This Chaotic Market
December 06, 2021
From Motley Fool
3 Beaten-Down Dividend Stocks -- Are They Bargins Now?
December 06, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.